346 related articles for article (PubMed ID: 22898389)
21. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
23. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
Misra R; Malik A; Singhal S
Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
[TBL] [Abstract][Full Text] [Related]
25. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Steinbach WJ; Benjamin DK; Kontoyiannis DP; Perfect JR; Lutsar I; Marr KA; Lionakis MS; Torres HA; Jafri H; Walsh TJ
Clin Infect Dis; 2004 Jul; 39(2):192-8. PubMed ID: 15307028
[TBL] [Abstract][Full Text] [Related]
26. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.
Azie N; Neofytos D; Pfaller M; Meier-Kriesche HU; Quan SP; Horn D
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):293-300. PubMed ID: 22789847
[TBL] [Abstract][Full Text] [Related]
27. [Aspergillus spp. isolations from respiratory tract samples in Trakya University Hospital].
Gürcan S; Demir M; Altiay G; Tikveşli M; Kiliç H; Otkun M
Tuberk Toraks; 2007; 55(2):160-6. PubMed ID: 17602344
[TBL] [Abstract][Full Text] [Related]
28. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
29. Current approaches to diagnosis and treatment of invasive aspergillosis.
Segal BH; Walsh TJ
Am J Respir Crit Care Med; 2006 Apr; 173(7):707-17. PubMed ID: 16387806
[TBL] [Abstract][Full Text] [Related]
30. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
31. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
32. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
[TBL] [Abstract][Full Text] [Related]
33. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
[TBL] [Abstract][Full Text] [Related]
34. Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.
Salman N; Törün SH; Budan B; Somer A
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):307-15. PubMed ID: 21417870
[TBL] [Abstract][Full Text] [Related]
35. Osteomyelitis caused by Aspergillus species: a review of 310 reported cases.
Gabrielli E; Fothergill AW; Brescini L; Sutton DA; Marchionni E; Orsetti E; Staffolani S; Castelli P; Gesuita R; Barchiesi F
Clin Microbiol Infect; 2014 Jun; 20(6):559-65. PubMed ID: 24303995
[TBL] [Abstract][Full Text] [Related]
36. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
37. Aspergillus calidoustus case series and review of the literature.
Seroy J; Antiporta P; Grim SA; Proia LA; Singh K; Clark NM
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28741738
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Aspergillus terreus at a university hospital.
Baddley JW; Pappas PG; Smith AC; Moser SA
J Clin Microbiol; 2003 Dec; 41(12):5525-9. PubMed ID: 14662934
[TBL] [Abstract][Full Text] [Related]
39. A retrospective study of the epidemiology and clinical manifestation of invasive aspergillosis in a major tertiary care hospital in Bahrain.
Alsalman J; Zaid T; Makhlooq M; Madan M; Mohamed Z; Alarayedh A; Ghareeb A; Kamal N
J Infect Public Health; 2017; 10(1):49-58. PubMed ID: 27033677
[TBL] [Abstract][Full Text] [Related]
40. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
